Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
85924722 | 8592472 | 2 | F | 20160914 | 20120601 | 20160920 | PER | US-ASTRAZENECA-2012SE05677 | ASTRAZENECA | 48.00 | YR | F | Y | 117.90000 | KG | 20160920 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
85924722 | 8592472 | 1 | PS | ATACAND HCT | CANDESARTAN CILEXETILHYDROCHLOROTHIAZIDE | 1 | Oral | 16/12.5 MG, ONE TABLET ONCE DAILY | U | 21093 | TABLET | ||||||||
85924722 | 8592472 | 2 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | U | 0 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||||
85924722 | 8592472 | 3 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | U | 0 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||||
85924722 | 8592472 | 4 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | U | 0 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||||
85924722 | 8592472 | 5 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | U | U | 0 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||||
85924722 | 8592472 | 6 | C | VALSARTAN HCTZ | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 120-12.5MG, DAILY | 0 | |||||||||||
85924722 | 8592472 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | 20 | MG | QD | |||||||||
85924722 | 8592472 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 81 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
85924722 | 8592472 | 2 | Post-traumatic stress disorder |
85924722 | 8592472 | 3 | Depression |
85924722 | 8592472 | 4 | Anxiety |
85924722 | 8592472 | 5 | Bipolar I disorder |
85924722 | 8592472 | 6 | Hypertension |
85924722 | 8592472 | 7 | Blood cholesterol abnormal |
85924722 | 8592472 | 8 | Cardiac disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
85924722 | 8592472 | Affect lability | |
85924722 | 8592472 | Asthenia | |
85924722 | 8592472 | Drug dose omission | |
85924722 | 8592472 | Feeling abnormal | |
85924722 | 8592472 | Pruritus generalised |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
85924722 | 8592472 | 6 | 2010 | 0 | ||
85924722 | 8592472 | 7 | 2010 | 0 | ||
85924722 | 8592472 | 8 | 2009 | 0 |